BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16966268)

  • 1. IgM multiple myeloma: report of four cases and review of the literature.
    Annibali O; Petrucci MT; Del Bianco P; Gallucci C; Levi A; Foà R; Avvisati G
    Leuk Lymphoma; 2006 Aug; 47(8):1565-9. PubMed ID: 16966268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM myeloma and Waldenstrom's macroglobulinemia: a distinct clinical feature, histology, immunophenotype, and chromosomal abnormality.
    Chehal A; Taher A; Shamseddine A
    Clin Lab Haematol; 2003 Jun; 25(3):187-90. PubMed ID: 12755797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [IgM myeloma: 6 cases and a review of the literature].
    De Gramont A; Grosbois B; Michaux JL; Peny AM; Pollet JP; Smadja N; Krulik M; Debray J; Bernard JF; Monconduit M
    Rev Med Interne; 1990; 11(1):13-8. PubMed ID: 2109345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia.
    Schuster SR; Rajkumar SV; Dispenzieri A; Morice W; Aspitia AM; Ansell S; Kyle R; Mikhael J
    Am J Hematol; 2010 Nov; 85(11):853-5. PubMed ID: 20842638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
    Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
    Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM myeloma: a report of four cases.
    Dierlamm T; Laack E; Dierlamm J; Fiedler W; Hossfeld DK
    Ann Hematol; 2002 Mar; 81(3):136-9. PubMed ID: 11904738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IgM myeloma: a report of 2 cases].
    Masanés F; Pedrol E; Bladé J; Casademont J; de la Sierra A; Martínez-Orozco F; Grau JM; Ingelmo M
    Med Clin (Barc); 1991 May; 96(20):777-9. PubMed ID: 1908542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IgM myeloma].
    Roujeau JC; Bisson M; Segond P; Massias P
    Sem Hop; 1976 Nov; 52(40):2277-82. PubMed ID: 188179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgM myeloma--its distinction from Waldenström's macroglobulinemia.
    Takahashi K; Yamamura F; Motoyama H
    Acta Pathol Jpn; 1986 Oct; 36(10):1553-63. PubMed ID: 3099541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM myeloma, a distinct entity in the spectrum of B-cell neoplasia.
    Zarrabi MH; Stark RS; Kane P; Dannaher CL; Chandor S
    Am J Clin Pathol; 1981 Jan; 75(1):1-10. PubMed ID: 6779622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders.
    Pangalis GA; Kyrtsonis MC; Kontopidou FN; Siakantaris MP; Dimopoulou MN; Vassilakopoulos TP; Tzenou T; Kokoris S; Dimitriadou E; Kalpadakis C; Tsalimalma K; Tsaftaridis P; Panayiotidis P; Angelopoulou MK
    Clin Lymphoma; 2005 Mar; 5(4):235-40. PubMed ID: 15794855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
    Morra E; Cesana C; Klersy C; Barbarano L; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Miqueleiz S; Bernuzzi P; Nosari AM; Lazzarino M
    Leukemia; 2004 Sep; 18(9):1512-7. PubMed ID: 15322559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma.
    Donovan KA; Lacy MQ; Gertz MA; Lust JA
    Leukemia; 2002 Mar; 16(3):382-5. PubMed ID: 11896542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
    Owen RG
    Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal macroglobulinemia with osteolytic lesions: a case report and review of the literature.
    Leb L; Grimes ET; Balogh K; Merritt JA
    Cancer; 1977 Jan; 39(1):227-31. PubMed ID: 401675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
    Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
    Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal clues apparently distinguishing Waldenstrom's macroglobulinemia from multiple myeloma and leukemia.
    Rothschild BM; Ruhli F; Rothschild C
    Am J Hum Biol; 2002; 14(4):532-7. PubMed ID: 12112574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.